Probiotics in reducing cardiovascular risk factors: a scoping review

Please use this identifier to cite or link to this item: http://dspace.nuph.edu.ua/handle/123456789/36318

Full metadata record

DC Field	Value	Language
dc.contributor.author	Melenevych, A.	-
dc.contributor.author	Verkhovodova, Y.	-
dc.contributor.author	Kuropiatnyk, O.	-
dc.date.accessioned	2026-03-25T07:37:03Z	-
dc.date.available	2026-03-25T07:37:03Z	-
dc.date.issued	2025	-
dc.identifier.citation	Melenevych, A. Probiotics in reducing cardiovascular risk factors: a scoping review / A. Melenevych, Y. Verkhovodova, O. Kuropiatnyk // Актуальні питання клінічної фармакології та клінічної фармації : матеріали наук.-практ. Internet-конф. з міжнар. участю, м. Харків, 28 жовт. 2025 р. – Харків : НФаУ, 2025. – С. 14-15.	uk_UA
dc.identifier.uri	http://dspace.nuph.edu.ua/handle/123456789/36318	-
dc.description.abstract	Background: Cardiovascular (CV) diseases are responsible for one-third of all deaths globally. Early assessment and prevention of CV risk are essential to reducing these deaths. Gut microbiota and its metabolites demonstrated benefits in reducing systemic inflammation and normalization of lipid profile. Probiotics may contribute to lowering CV risk by optimizing the gut-heart axis.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	НФаУ	uk_UA
dc.subject	Cardiovascular (CV) diseases	uk_UA
dc.title	Probiotics in reducing cardiovascular risk factors: a scoping review	uk_UA
dc.type	Article	uk_UA
Appears in Collections:	Тези доповідей співробітників НФаУ

Files in This Item:

File	Description	Size	Format
Зб. конф. Актуальні пит 25.10.25 14-15.pdf		735,18 kB	Adobe PDF	View/Open